Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

AstraZeneca to build $285m biologics manufacturing facility in Sweden British drugmaker AstraZeneca is investing around $285m to build a new manufacturing facility for biological medicines in Södertälje, Sweden. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

Regen BioPharma files patent application on mRNA dendritic cell cancer immunotherapeutic
Regen BioPharma announced the filing of a United States patent application covering mRNA delivered tumor antigens to dendritic cells as a means of inducing tumor immunity.
News
Eisai gets EMA Committee positive opinion for Fycompa to treat PGTC seizures
By PBR Staff Writer
Eisai's UK subsidiary Eisai Europe has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the use of Fycompa (perampanel) for the adjunctive treatment of primary generalized tonic-clonic (PGTC) seizures.
News

OTC

FDA approves Actavis' Viberzi to treat irritable bowel syndrome with diarrhea in adults
By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted approval for Irish OTC firm Actavis' Viberzi (eluxadoline) as a twice-daily, oral treatment for adults suffering from irritable bowel syndrome with diarrhea (IBS-D), a multifactorial disorder.
News
PharmaCenter to begin marketing EastGate's nutraceutical products
By PBR Staff Writer
US company EastGate Biotech has selected Hungary-based PharmaCenter to market E-drops, one of the company's nutraceutical products in Slovakia and Czech Republic.
News

Manufacturing

AbbVie acquires cancer drugmaker Pharmacyclics for $21bn
AbbVie has acquired cancer drugmaker Pharmacyclics for $21bn, further strengthening its scientific and commercial presence in oncology.
News
Ergomed takes over medical information service provider Sound Opinion
By PBR Staff Writer
UK-based Ergomed has made the strategic acquisition of Sound Opinion, one of the UK’s leading Medical Information (MI) service providers.
News